Adaptive Biotechnologies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
ADPT Key Statistics
Stock Snapshot
With a market cap of 3.01B, Adaptive Biotechnologies(ADPT) trades at $19.85. The stock has a price-to-earnings ratio of -36.65.
During the trading session on 2025-11-28, Adaptive Biotechnologies(ADPT) shares reached a daily high of $20.36 and a low of $19.25. At a current price of $19.85, the stock is +3.1% higher than the low and still -2.5% under the high.
Trading volume for Adaptive Biotechnologies(ADPT) stock has reached 1.88M, versus its average volume of 2.85M.
Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $20.76 and a low of $5.52.
Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $20.76 and a low of $5.52.
ADPT News
Adaptive Biotechnologies (ADPT) announced that its next-generation sequencing-based clonoSEQ test for measurable residual disease assessment will be included in...
In the past week, Adaptive Biotechnologies reported third quarter results that surpassed market expectations, citing robust performance in its minimal residual...
